Molecular and Neural Circuitry Mechanisms Underlying Antidepressant Treatment Resistance
抗抑郁药治疗耐药性的分子和神经回路机制
基本信息
- 批准号:10087961
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-16 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Activin ReceptorActivinsAddressAdultAffectAntidepressive AgentsAnxietyBehaviorBehavioralChronicComplexDataDisease remissionEffexorFluoxetineFundingFutureGene ExpressionGeneralized Anxiety DisorderGoalsGrowth FactorIndividualInfusion proceduresLeadLearningMajor Depressive DisorderMapsMediatingMediator of activation proteinMemoryMental disordersModernizationModificationMolecularMusObsessive-Compulsive DisorderParahippocampal GyrusPharmaceutical PreparationsPopulationReportingResearchSelective Serotonin Reuptake InhibitorSerotonin Receptor 5-HT1ASignal TransductionStressTechniquesTestingTransforming Growth Factor betaWorkactivin Aadult neurogenesisbasebehavior testbehavioral responsedentate gyrusdepressive symptomsdesigndesigner receptors exclusively activated by designer drugsemotional behaviorexperiencegranule cellhypothalamic-pituitary-adrenal axisimprovedneural circuitneuropsychiatrypatient subsetsprogramsresponders and non-respondersresponsetherapy resistantvenlafaxineyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
Approximately 32-35 million adults in the US population (16%) experience an episode of major
depression in their lifetime, and commonly used treatments, such as selective serotonin reuptake inhibitors
(SSRIs), are not ideal since only a subset of patients (~33%) achieves remission with initial treatment. The
reasons why some individuals remit to antidepressant treatments while others do not are unknown. Given that
antidepressants such as SSRIs are also commonly used to treat other psychiatric disorders, such as
generalized anxiety disorder and obsessive-compulsive disorder, it is of critical importance to determine the
differences between remitters and non-remitters to antidepressant treatment. Our overall research program
addresses this question by assessing antidepressant treatment resistance in mice. Preliminary data indicate
that both molecular and neural-circuit based approaches to modifying the dentate gyrus may be able to convert
behavioral non-responders to fluoxetine (a SSRI) into responders. Further preliminary data indicate that these
approaches may also work as augmentation strategies for several other classes of antidepressants. The
Specific Aims are: 1) Test the hypothesis that Activin signaling based modifications of dentate gyrus can alter
the behavioral response to fluoxetine through modulation of young adult-born granule cells; 2) To test the
hypothesis that circuit-based approaches to silencing mature dentate gyrus granule cells can alter the
behavioral response to fluoxetine and to determine whether there are functional differences in DG inputs
between responders and non-responders; and 3) Test the hypothesis that alterations in DG granule cells are a
common feature of behavioral non-response to different antidepressant treatments.
项目概要/摘要
美国人口中大约有 32-3500 万成年人 (16%) 经历过重大疾病发作
一生中的抑郁症以及常用的治疗方法,例如选择性血清素再摄取抑制剂
(SSRIs)并不理想,因为只有一部分患者(约 33%)通过初始治疗获得缓解。这
有些人接受抗抑郁治疗而另一些人却没有接受治疗的原因尚不清楚。鉴于
SSRIs 等抗抑郁药也常用于治疗其他精神疾病,例如
广泛性焦虑症和强迫症,确定其症状至关重要
汇款人和非汇款人在抗抑郁治疗方面的差异。我们的总体研究计划
通过评估小鼠抗抑郁治疗的抵抗力来解决这个问题。初步数据表明
基于分子和神经回路的方法来修改齿状回可能能够将
将氟西汀(一种 SSRI)行为无反应者转变为反应者。进一步的初步数据表明,这些
这些方法也可以作为其他几种抗抑郁药的增强策略。这
具体目标是: 1) 检验基于激活素信号传导的齿状回修饰可以改变的假设
通过调节年轻成年颗粒细胞对氟西汀的行为反应; 2) 测试
假设基于电路的方法沉默成熟的齿状回颗粒细胞可以改变
对氟西汀的行为反应并确定 DG 输入是否存在功能差异
响应者和非响应者之间; 3) 检验 DG 颗粒细胞的改变是一个假设
对不同抗抑郁治疗行为无反应的共同特征。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Behavioral response to fluoxetine in both female and male mice is modulated by dentate gyrus granule cell activity.
雌性和雄性小鼠对氟西汀的行为反应均受齿状回颗粒细胞活性的调节。
- DOI:10.1016/j.ynstr.2020.100257
- 发表时间:2020-11
- 期刊:
- 影响因子:5
- 作者:Yohn CN;Dieterich A;Maita I;Bazer AS;Diethorn E;Ma D;Gergues MM;Hu P;Samuels BA
- 通讯作者:Samuels BA
Social instability is an effective chronic stress paradigm for both male and female mice.
对于雄性和雌性小鼠来说,社会不稳定是一种有效的慢性压力范例。
- DOI:10.1016/j.neuropharm.2019.107780
- 发表时间:2019
- 期刊:
- 影响因子:4.7
- 作者:Yohn,ChristineN;Ashamalla,SandraA;Bokka,Leshya;Gergues,MarkM;Garino,Alexander;Samuels,BenjaminA
- 通讯作者:Samuels,BenjaminA
Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice.
- DOI:10.3791/61548
- 发表时间:2020-08-13
- 期刊:
- 影响因子:0
- 作者:Dieterich A;Yohn CN;Samuels BA
- 通讯作者:Samuels BA
The role of 5-HT receptors in depression.
- DOI:10.1186/s13041-017-0306-y
- 发表时间:2017-06-24
- 期刊:
- 影响因子:3.6
- 作者:Yohn CN;Gergues MM;Samuels BA
- 通讯作者:Samuels BA
Chronic non-discriminatory social defeat stress reduces effort-related motivated behaviors in male and female mice.
- DOI:10.1038/s41398-021-01250-9
- 发表时间:2021-02-15
- 期刊:
- 影响因子:6.8
- 作者:Dieterich A;Liu T;Samuels BA
- 通讯作者:Samuels BA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN A SAMUELS其他文献
BENJAMIN A SAMUELS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN A SAMUELS', 18)}}的其他基金
Molecular and Neural Circuitry Mechanisms Underlying Antidepressant Treatment Resistance
抗抑郁药治疗耐药性的分子和神经回路机制
- 批准号:
9288517 - 财政年份:2017
- 资助金额:
$ 38.75万 - 项目类别:
Molecular and Neural Circuitry Mechanisms Underlying Antidepressant Treatment Resistance
抗抑郁药治疗耐药性的分子和神经回路机制
- 批准号:
9435165 - 财政年份:2017
- 资助金额:
$ 38.75万 - 项目类别:
Mechanisms Underlying Treatment-Resistant Depression and Anxiety in Mouse Models
小鼠模型中难治性抑郁和焦虑的机制
- 批准号:
8352866 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:
Mechanisms Underlying Treatment-Resistant Depression and Anxiety in Mouse Models
小鼠模型中难治性抑郁和焦虑的机制
- 批准号:
8509029 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:
相似国自然基金
产酸拟杆菌通过代谢产物N-乙酰血清素激活IDO1-AhR信号介导Treg-巨噬细胞轴减轻脓毒症肝损伤的作用及机制
- 批准号:82330067
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
游离脂肪酸激活PPARG上调III型干扰素通路抑制食管鳞癌的作用机制研究
- 批准号:82372708
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
电针激活大麻素CB1受体抑制mPFC–LS环路缓解应激性焦虑的机制
- 批准号:82374584
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
青蒿素纳米反应器诱导铁死亡激活STING调控巨噬细胞极化抗肺癌及机制研究
- 批准号:82304552
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
印度梨形孢激活根系质子泵促进水稻高效利用土壤磷素的调控机制
- 批准号:42307419
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD
CKD-MBD 病理生理学和治疗的新进展
- 批准号:
10440482 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10457087 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD
CKD-MBD 病理生理学和治疗的新进展
- 批准号:
10298983 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD
CKD-MBD 病理生理学和治疗的新进展
- 批准号:
10609908 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别: